Upper airways involvement in bronchial asthma

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 1, 1998, Pages 54-58

  Glovsky, M Michael ^a  

^a HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ASTHMA; HUMAN; NOSE POLYP; NOSE PROVOCATION TEST; PERENNIAL RHINITIS; PHYSIOLOGY; REVIEW; SINUSITIS;

ASTHMA; CYTOKINES; HUMANS; NASAL POLYPS; NASAL PROVOCATION TESTS; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS;

EID: 0031612251     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199801000-00011     Document Type: Article

References (24)

1. Glovsky MM, Schwartz MS: Upper airways involvement in pulmonary disease. Semin Respir Med 1988, 9:449-458. These authors outline anatomy and mechanisms of rhinitis, polyps, and sinusitis and discuss composition of mucous in the nose and bronchial tree.
2. Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery, JC, Shapiro J, Cohn J, Rubin P, Drazen JM: The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993, 148:1447-1451.
3. Kaliner M, Wasserman SI, Austin KF: Immunologic release of chemical mediators from human nasal polyps. N Engl J Med 1973, 289:277-281.
4. Berman SJ, Mathison DA, Stevenson DD, Usselman JA, Shore S, Tan EM: Maxillary sinusitis and bronchial asthma: correlation of roentgenographs, culture and thermograms. J Allergy Clin Immunol 1974, 53:311-317.
5. Rachelefsky GS, Katz RM, Siegel SC: Chronic sinus disease with associated reactive airway disease in children. Pediatrics 1984, 783:526-529.
6. Andersen I, Lundqvist G, Jensen PL, Proctor DF: Human response to controlled levels of sulfur dioxide. Arch Environ Health 1974, 28:31-39.
7. Anderson I, Lundqvist G, Proctor DF: Human response to controlled levels of inert dust. Am Rev Respir Dis 1979, 119:619-627.
8. Kaufman J, Chen JC, Wright GW: The effect of trigeminal resection on reflex bronchoconstriction after nasal and nasopharyngeal irritation in man. Am Rev Respir Dis 1970, 101:768-769.
9. Kaufman J, Wright GW: The effect of nasal and nasopharyngeal irritation on airway resistance in man. Am Rev Respir Dis 1969, 100:626.
10. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial responsiveness in rhinitis. J Allergy Clin Immunol 1985, 75:573-577.
11. Lemanske RF Jr, Dick EC, Swenson CA, Vritis RF, Busse WW: Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989, 83:1-10.
12. Naclerio RM, Proud D, Togias AG, Adkinson NF Jr, Meyers DA, Kagey Sobotka A, Plaut M, Norman PS, Lichtenstein LM: Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985, 313:65-70.
13. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF Jr, Kagey-Sobotka A, Norman PS, Lichtenstein LM: Nasal challenge with cold, dry air results in release of inflammatory mediators: possible mast cell involvement J Clin Invest 1985, 76:1375-1381.
14. Lukacs NW, Strieter RM, Kurkel SL: Adhesion molecules, cytokines and chemokines in allergic airways inflammation in leucocytes. In Allergic Airways Inflammation. Edited by Bochner B. New York: Marcel Dekker; 1997. A good review of experimental data in adhesion molecules and cytokines related to experimental airway disease.
15. Wegner CD, Gundel RH, Letts LG: Expression and probable roles of cell adhesion molecules in lung inflammation. Chest 1992, 101:34s-39s.
16. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R: Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990, 247:456-459.
17. Mauser PJ, Pittman A, Witt A: Inhibitory effect of the TRFK-5 ant IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993, 148:1623-1627.
18. Springer TA, Dustin ML, Kishimoto TK, Martin SD: The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987, 5:223-252.
19. Gosset P, Tsicopoulos A, Walloert B, Joseph M, Capron A, Tonnel AB: Tumor-necrosis factor alpha, IL-6 production by human mononuclear phagocytes from allergic asthmatics after IgE dependent stimulation. Am Rev Respir Dis 1992, 146:768-774.
20. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ: The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994, 144:321-328.
21. Henriksen JW, Wenzel A: Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing and asthma. Am Rev Respir Dis 1984, 130:1014-1018.
22. Aubier M, Clerici C, Neukirch F, Herman D: Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992, 146:122-126.
23. Grant JA, Nicodermus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, Meltzer EO, Mitchell DQ, Pearlman D, Selner J, et al.: I: Cetirizine in patients with seasonal allergic rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995, 95:923-932. Antihistamines (cetirizine) effective in relieving both rhinitic and asthmatic symptoms in seasonal rhinitis and asthma are discussed. No contraindication for antihistamines in asthma were found.
24. Corren J: Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997, 99:2, 5781-5786.